Longevity Fund 2 LP is > 10% Shareholder of Decibel Therapeutics, Inc.. Currently has a direct ownership of 79,143 shares of DBTX, which is worth approximately $0. The most recent transaction as insider was on Feb 17, 2021, when has been sold 79,143 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.1K
0% 3M change
0% 12M change
Total Value Held $0

Longevity Fund 2 LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2021
BUY
Conversion of derivative security
-
79,143 Added 50.0%
79,143 Common Stock
LF2

Longevity Fund 2 LP

> 10% Shareholder
Palo Alto, CA

Track Institutional and Insider Activities on DBTX

Follow Decibel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DBTX shares.

Notify only if

Insider Trading

Get notified when an Decibel Therapeutics, Inc. insider buys or sells DBTX shares.

Notify only if

News

Receive news related to Decibel Therapeutics, Inc.

Track Activities on DBTX